Chun‐Choo Kim
Catholic University of Korea(KR)
Publications by Year
Research Areas
Hematopoietic Stem Cell Transplantation, Acute Lymphoblastic Leukemia research, Chronic Myeloid Leukemia Treatments, Acute Myeloid Leukemia Research, Eosinophilic Disorders and Syndromes
Most-Cited Works
- → Risk factors for adults with Philadelphia‐chromosome‐positive acute lymphoblastic leukaemia in remission treated with allogeneic bone marrow transplantation: the potential of real‐time quantitative reverse‐transcription polymerase chain reaction(2002)64 cited
- → Cutaneous leucoclastic vasculitis (LV) following bortezomib therapy in a myeloma patient; association with pro‐inflammatory cytokines(2006)55 cited
- → The extent of minimal residual disease reduction after the first 4‐week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome‐positive acute lymphoblastic leukemia(2009)49 cited
- → Comprehensive comparison of FISH, RT‐PCR, and RQ‐PCR for monitoring the BCR‐ABL gene after hematopoietic stem cell transplantation in CML(2002)35 cited
- → Molecular Epidemiological Analysis of Quinolone‐ResistantEscherichia coliCausing Bacteremia in Neutropenic Patients with Leukemia in Korea(1997)31 cited
- → Influence of karyotype on outcome of allogeneic bone marrow transplantation for adults with precursor B‐lineage acute lymphoblastic leukaemia in first or second remission(2002)18 cited
- → Successful interim therapy with imatinib prior to allogeneic stem cell transplantation in Philadelphia chromosome‐positive acute myeloid leukemia(2007)15 cited
- → Gemtuzumab ozogamicin in combination with attenuated doses of standard induction chemotherapy can successfully induce complete remission without increasing toxicity in patients with acute myeloid leukemia aged 55 or older(2007)15 cited
- → Interpretation of interleukin‐2 receptor alpha positive cells during induction chemotherapy for adult acute myelogenous leukaemia patients(2007)10 cited
- → Paroxetine in the treatment of depressed patients with haematological malignancy: an open‐label study(2004)10 cited